Cargando…
Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?
In the current era of the COVID-19 pandemic, the world has never been more interested in the process of vaccine development. While researchers across the globe race to find an effective yet safe vaccine to protect populations from the newly emergent SARS-CoV-2 virus, more than one-third of the world...
Autores principales: | Dhanda, Sandeep, Osborne, Vicki, Lynn, Elizabeth, Shakir, Saad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785063/ https://www.ncbi.nlm.nih.gov/pubmed/33087452 http://dx.doi.org/10.1136/bmjebm-2020-111507 |
Ejemplares similares
-
Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies
por: Ioannidis, John P A
Publicado: (2022) -
EMA’s mishandling of an investigation into suspected serious neurological harms of HPV vaccines
por: Gøtzsche, Peter C, et al.
Publicado: (2022) -
COVID-19 and the US response: accelerating health inequities
por: Okonkwo, Nneoma E, et al.
Publicado: (2021) -
Different knowledge, different styles of reasoning: a challenge for guideline development
por: Wieringa, Sietse, et al.
Publicado: (2018) -
Enabling individualised health in learning healthcare systems
por: Wongvibulsin, Shannon, et al.
Publicado: (2020)